生物活性 | |||
---|---|---|---|
描述 | hCAI/II-IN-6, an orally active human carbonic anhydrase (CA) inhibitor, selectively inhibits hCA II and hCA VII isoforms with Ki values of 220, 4.9, 6.5, and >50000 nM for hCA I, hCA II, hCA VII, and hCA XII, respectively. It exhibits anticonvulsant and anti maximal electroshock (MES) activities in vivo, suitable for epilepsy research [1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.57mL 0.51mL 0.26mL |
12.87mL 2.57mL 1.29mL |
25.74mL 5.15mL 2.57mL |
参考文献 |
---|